Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Rapport Therapeutics, Inc.
RAPP
Operating margin
Operating margin at other companies
Supernus Pharmaceuticals
SUPN
-7.8%
-18.9pp
Xenon Pharmaceuticals
XENE
-4,974.3%
—
Praxis Precision Medicines, Inc.
PRAX
-3,927.5%
-1,497pp
Septerna, Inc.
SEPN
-77.1%
-38.4pp
Taysha Gene Therapies, Inc.
TSHA
-1,774.4%
+1,437pp
Acadia Pharmaceuticals
ACAD
7.4%
-16.2pp
Other financials
Income statement
See full
Revenue
$20.0M
—
Operating income
-$24.2M
+10.7%
Net income
-$19.9M
+17.5%
EPS (diluted)
-$0.42
+38.2%
Balance sheet
See full
Cash & equivalents
$78.1M
+35.5%
Total debt
$10.8M
+37.8%
Total equity
$471.5M
+65.0%
Total assets
$497.6M
+64.7%
Cash flow
See full
Operating cash flow
-$13.1M
+35.5%
CapEx
$86.0K
-70.4%
Free cash flow
-$13.1M
+36.0%
Valuation
See full
Market cap
$1.91B
+309%
Returns & leverage
See full
Return on equity
-28.3%
—
Debt / equity
0×
0.0×
Current ratio
27.1×
-3.9×